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Fibronectin, a class of adhesive, high-molecular-weight glycoproteins, is present in 
connective  tissue,  primative  mesenchyme,  basement  membranes,  amniotic  fluid, 
cerebrospinal  fluid,  and  plasma  (1,  2).  A  variety  of cells  synthesize  fibronectin; 
however, the amount of fibronectin present on the surface of transformed or neoplastic 
cells is greatly reduced  (1-3). The biological properties of fibronectin are numerous. 
It is known that fibronectin promotes cellular aggregation, cell-substratum adhesive- 
ness, partially restores transformed fibroblasts to a more normal appearance, promotes 
locomotion of certain types of cells, facilitates reticuloendothelial system clearance of 
colloids, and specifically binds to macromolecules such as types I, II, and III collagens, 
fibrin,  fibrinogen,  heparin,  and  actin  (1-9).  Plasma  and  cellular  fibronectin  are 
structurally similar, share immunological identity, and have many common biological 
properties (2). 
Fibronectin is a substrate for plasma transglutaminase, thrombin plasmin, cathepsin 
D, leukocyte elastase, trypsin, chymotrypsin, and subtilisin  (3,  10-13). It is composed 
of two  almost  identical,  polypeptide  chains  with  a  220,000  mol  wt  (2).  Limited 
proteolysis of fibronectin yields fragments that retain some of the biologic activities 
ascribed to the native molecule (12-15). For example, cathepsin D cleavage produces 
a  major 72,000-mol wt fragment that possesses gelatin-binding activity and a  major 
137,000-mol wt fragment that lacks gelatin-binding activity (12,  14). 
Mechanisms that control the organization, distribution, and migration of connective 
tissue  fibroblasts  in  vivo under  pathologic  and  normal  physiologic  conditions  are 
poorly understood.  An  assay that  measures chemotactic  (directional)  migration  of 
human fibroblasts in vitro has been developed in our laboratory (16).  By employing 
this  assay,  it  has  been  possible  to  isolate  and  identify  specific substances  that  are 
capable of effecting chemotactic migration of fibroblasts (16-19). In t he present study, 
we have observed that plasma and cellular fibronectin induce chemotactic migration 
of fibroblasts  in  vitro.  The  region  of the  fibronectin  molecule  responsible  for  its 
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chemotactic activity is contained in a  major  140,000-mol wt fragment  generated  by 
cathepsin D  cleavage. This chemotactic fragment lacks gelatin-binding activity. 
Materials  and Methods 
Purification of Fibronectin.  Fibronectin was purified from normal human citrated plasma and 
supernates  obtained  from cultures  of human  lung  fibroblasts  by the  technique  of affinity 
chromatography employing a  gelatin-agarose column (9). The affinity column was prepared 
by coupling gelatin  obtained from type I  rat  skin collagen to cyanogen bromide-activated 
Sepharose  4B  particles  (Pharmacia  Fine  Chemicals,  Div.  of Pharmacia,  Inc.,  Piscataway, 
N. J.).  After the column was washed extensively with phosphate-buffered saline plus 0.2 M 
KBr, adsorbed fibronectin was eluted  from the column with  1 M  KBr in 0.05  M  Tris-HCl 
buffer (pH 5.3)  as originally described  (20, 21).  Fibronectin recovered from the column was 
dialyzed against Tris-HCI buffer (pH 8.3) and was stored either at -70°C or in the lyophilized 
state at -20°C in a dessicator. The purity of fibronectin was analyzed by polyacrylamide gel 
electrophoresis  in  the  presence  of sodium  dodecyl  sulphate.  Protein  stainings  of the  gels 
indicated >98% purity. 
Fibroblast Chemotaxis.  Fibroblast  chemotaxis  was  measured  as  previously described  (16). 
Indicator cells used in the assay were human  foreskin  fibroblasts harvested from monolayer 
cultures by trypsinization. Serum-free suspensions of harvested fibroblasts were placed in the 
upper compartments of blind-well chemotaxis chambers equipped with porous (8 #m) gelatin- 
treated polycarbonate filters.  Test substances were added to the compartment below the filter 
and, in some experiments, also to the upper compartment of each chamber. After a  150-rain 
incubation  at  37°C,  fibroblast  chemotaxis  was  quantitated  by  counting  the  number  of 
fibrohlasts that migrated through the pores to the lower surface of  each filter in 20 oil immersion 
fields  (OIF). All samples were tested in triplicate.  Final chemotactic activity was expressed as 
the mean :1: SEM of the replicates. 
Monocytes and Neutrophil Chemotaxis.  Chemotaxis of human peripheral blood monocytes and 
neutrophils was measured as previously described (22). 
Isolation of Gelatin-binding and Non-Gelatin-binding Fragments of Fibronectin.  Plasma fibronectin 
was digested with cathepsin D  (Sigma Chemical Co., St. Louis, Mo.) at pH 3.5 and 30°C in 4 
h as previously described (12, 14, 23). The reaction was terminated by the addition of a  10-fold 
molar excess of pepstatin A (Peptide Research Institute, Osaka, Japan). The reaction products 
were brought  to neutral  pH  by addition  of 1.5  M  Tris,  pH  8.8,  and  applied  to a  gelatin- 
Sepharose column as previously described (12,  14). Non-gelatin-binding fragments were col- 
lected in the fall-through, and gelatin-binding fragments were eluted from the column with 6 
M  urea  as  previously described  (12,  14)  at  25°0.  Chromatography of non-gelatin-binding 
fragments and plasma fibronectin was achieved on a  1.0- ×  100-cm column of Sephadex G-200 
equilibrated  with 0.015 M  glycylglycine/0.14 M  NaCI at pH 7.2. Protein content of column 
fractions was determined by Bio-Rad Protein Assay (Bio-Rad Laboratories, Richmond, Calif.). 
Results 
Chemotactic Property of Fibronectin.  Plasma  fibronectin  stimulated  the migration  of 
fibroblasts  in  a  dose-dependent  manner,  with  maximal  migration  occurring  at  a 
concentration  of  1.2  #g/ml  (Fig.  1).  However,  plasma  fibroneetin  did  not  induce 
migration of human neutrophils or monocytes at concentrations ranging from 0.4 to 
100 #g/ml (data not shown). 
Zigmond-Hirsch checkerboard analysis revealed that fibronectin-induced migration 
of fibroblasts when it was present  in higher concentration in the lower compartment 
of the  chemotaxis chambers  (Table  I). These data  suggest  that  fibronectin  induces 
fibroblast migration by acting as a  ehemoattraetant  (24). 
To confirm that fibroblasts were migrating in response to a gradient of fibronectin 
and  not  to other substances  that  could he present  in  small  amounts  in  fibronectin 
preparations,  fibronectin  was  chromotographed  on  Sephadex  G-200.  Chemotactic 
activity co-eluted with fibronectin  (data not shown). 496  POSTLETHWAITE  ET  AL.  BRIEF  DEFINITIVE  REPORT 
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FIG.  l.  Plasma fibronectin was dissolved in MEM  and assayed at the concentrations indicated for 
its ability to induce fibroblast migration. 
Fro.  2.  Non-gelatin-binding fragments were derived  from cathepsin  D  cleavage of plasma fibro- 
nectin  and  were  purified  by  affinity  chromatography  as  described  in  Materials  and  Methods. 
Isolated non-gelatin-binding fragments (1 mg) were chromatographed on a  Sephadex G-200 column 
as  described  in  Materials  and  Methods,  and  column  fraction were  diluted  50%  with  MEM  and 
tested for chemotactic activity. VE, Volume of eluent; VTHO, volume of tritiated water. 
TABLE  I 
Effect of Varying Concentration Gradients of Fibronectin on Fibroblast Migration* 
Fibronectin concentration 
in upper compartment 
Fibronectin concentration in lower compartment (gg/ml) 
1.2  I.(}  0,8  0.6  {} 
gg/ml 
1.2 
1.0 
0.8 
0.6 
0 
Fibroblasts/20 OIF 
"~Q!...~~  3+1  3_+1  3+1 
16--+2  ~,~~.._  6-+1  6_+1 
31-+1  17:t,-2  ~.  ~,~  5-+1 
78+._',3  61_+ 7  44 _+ 5  32 -+ 5~ 
* Different concentrations of plasma fibronectin were added to the upper and lower compartments of the chemotaxis 
chambers, and the number of fibroblasts migrating to the lower surface of each filter was quantitated. 
TABLE II 
Induction of F,'broblast Migration by Cell-Derived Fibronectin* 
Fibronectin concentration  Chemotactic activity 
gg/ml  Fibroblasts/20 OIF 
50.0  4 _+ I 
51)  4 -  1 
2.50  13 _+ 1 
1.25  61 +  5 
0,75  32 +  4 
I),25  11 +  1 
MEM  3 +_  1 
* Cell-derived fibronectin was dissolved in minimum essential medium (MEM) and tested 
for chemotactic activity. 
It was of interest to determine whether fibronectin of cellular origin was as effective 
as plasma-derived  fibronectin  in  inducing  fibroblast  migration.  Migration  of fibro- 
blasts was observed at concentrations of cell-derived fibronectin between 0.75 and 2.5 
gg/ml, similar to that obtained with plasma-derived fibronectin (Table II and Fig.  1). 
Fibronectin Fragments.  It  was  of interest  to  determine  whether  gelatin-binding  or 
non-gelatin-binding fragments resulting from cleavage of fibronectin by cathepsin D 
retained  chemotactic  activity.  Non-gelatin-binding  fragments  were  chemotactic  at POSTLETHWAITE ET AL.  BRIEF  DEFINITIVE REPORT 
TABLE lII 
Migration of Fibroblasts to Gelatin-binding and Non-Gelatin-binding 
Fragments of Fibronectin 
Fragment concentration 
Chemotactic activity 
Gelatin-binding  Non-gelatin-binding 
gg/ml  Fibroblasts/20 OIF 
50.0  5--+  1  21-+  1 
20.0  3 -+  1  47 _-. 5 
10.0  5 +2  66-+5 
5.0  4±  l  51:t:5 
2.5  4-+  1  17-+2 
1.6  3-+1  6-+1 
0.8  3_+2  4-+1 
* Plasma fibronectin  was cleaved by cathepsin D, and gelatin-binding and  non-gelatin- 
binding fragments were isolated by affinity chromatography as described in Materials 
and Methods and tested in the same experiment for chemotactic activity. 
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concentrations ranging from 2.5 to 50 gg/ml, with maximal response occurring at  10 
gg/ml  (Table III).  Fibroblasts  did not  migrate in response to gelatin-binding frag- 
ments (Table III). 
To determine  the  approximate size  of the  active fragment,  non-gelatin-binding 
fragments were chromatographed on  Sephadex G-200,  and  column  fractions were 
tested for chemotactic activity (Fig. 2).  A single peak of chemotactic activity eluted 
from the column just afier the 160,000-mol wt marker (Fig. 2). 
Discussion 
Fibronectin of plasma or cellular origin is chemotactic for human dermal fibroblasts 
in vitro. After cleavage of fibronectin by cathepsin D, chemotactic activity is found in 
a  non-gelatin-binding  fragment  having an  estimated  molecular weight  of 140,000. 
Gelatin-binding fragments do not possess  chemotactic activity. 
Although the mechanism by which fibronectin causes the chemotactic migration of 
fibroblasts is not apparent from this study, these data strongly suggest that fibronectin 
does not produce its effect by acting as a simple ligand between cell surface.receptor 
and the gelatin-coated polycarbonate fhers. Additional data that  do not support a 
ligand role for fibronectin in its induction of fibroblast chemotaxis are the findings 
that  (a)  the  amount  of gelatin  deposited  on  each  surface  of the  gelatin-treated 
polycarbonate  filter  used  in  the  chemotaxis  assay  is  <4  ng,  (b)  preincubation  of 
gelatin-treated filters with  fibronectin (4 gg/ml)  for  150  min at  37°C,  followed by 
rinsing  in  distilled  water  does  not  alter the chemotactic response of fibroblasts  to 
fibronectin, and  (c) fibroblasts also respond chemotactically to fibronectin when the 
polycarbonate filters are treated with the synthetic peptide glycyl-prolyl-L-hydroxy- 
proline (A. Postlethwaite. Unpublished observations.). 
The  concentration  of fibronectin  in  plasma  is  -300  gg/ml  (2).  In  this  study, 
fibroblasts were responsive to lower concentrations (0.4-2 gg/ml) of native fibronectin, 
however, higher concentrations of cathepsin  D-generated non-gelatin-binding frag- 
ments were required to effect fibroblast migration. Higher concentrations (>2 #g/ml) 
of native fibronectin elicited no migration. A similar bell-shaped dose-response curve 
has been observed in the chemotaxis of neutrophiis to formylmethionyl peptides (25). 
The diminished response to large amounts of chemoattractant may result from rapid 
diffusion of the chemoattractant to the upper cell compartment, with a concomitant 498  POSTLETHWAITE ET AL.  BRIEF DEFINITIVE REPORT 
saturation of available receptors on plasma membranes on the responding cells. It is 
also possible that  fibroblasts in  vivo respond optimally to higher concentrations  of 
fibronectin than they do in vitro under the artificial conditions of the assay system 
employed in this study. 
Fibronectin and/or its biologically active fragments may play a significant role in 
effecting fibroblast migration in vivo. The role of fibronectin as a fibroblast chemoat- 
tractant should be considered in relation to other chemotactic factors for fibroblasts 
we have previously described  (16-19).  Specific chemotactic lymphokines have been 
characterized for human and guinea pig fibroblasts (16,  17). These lymphokines could 
be  released  at  sites  of cell-mediated  immune  reactions  in  vivo.  A  fragment  from 
human C5 is also chemotactic for fibroblasts, suggesting that the complement system 
when  activated  could  provide  a  specific  chemoattractant  for  fibroblasts  (18).  In 
addition, collagen and collagen-derived peptides are chemotactic for fibroblasts (19). 
Because collagen  and  fibronectin  are both  present  in  the connective tissue  matrix, 
their degradation by specific proteinases during the course of inflammatory reactions 
of  all  types  could  generate  additional  chemotactic  signals  for  fibroblasts.  Thus, 
collagen-derived peptides and biologically active fibronectin peptides could serve as 
important  amplifiers of fibroblast chemotaxis and could greatly facilitate the accu- 
mulation of fibroblasts at sites of connective tissue injury and inflammation. During 
embryonic development and morphogenesis, the chemotactic property of fibronectin 
and derived peptides could function to direct migration of fibroblasts to effect specific 
organization of connective tissue. 
Summary 
Plasma and cell-derived fibronectin are potent chemoattractants for human dermal 
fibroblasts  in  vitro.  The  chemotactic  property  of  fibronectin  resides  in  a  major 
140,000-tool wt non-gelatin-binding fragment of the native molecule. Human mono- 
cytes and neutrophils do not recognize fibronectin as a  chemotactic stimulus. These 
findings suggest that  fibronectin and perhaps certain  fragments of fibronectin may 
function  in  vivo as a  specific chemoattractant  for fibroblasts and  could,  therefore, 
induce  directional  migration  of fibroblasts  to  sites  of tissue  injury,  remodeling  or 
morphogenesis. 
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